Maze Therapeutics Corp (MAZE) - Kapitalizatsiyaning foydaga nisbati

Maze Therapeutics, Inc. (MAZE) korporativ emblemasi va logotipi

Maze Therapeutics Inc (MAZE) G'arb mamlakatlarida sanksiyalar bosimidan xoli, barqaror huquqiy asoslar doirasida gen terapiyalarini ishlab chiqmoqda. Biznesning o'sishi kamyob metabolik patologiyalarga qarshi kichik molekulalarning yaratilishi va Sanofi tomonidan ko'rsatilayotgan qo'llab-quvvatlash bilan ta'minlanmoqda. Biroq, patentlar va genetik iste'dodlar uchun raqobat sezilarli xatarlarni yuzaga keltirmoqda. Emitentning P/E dinamikasi bozor kutganlarini aks ettiradi va ushbu ko'rsatkich -12.90 darajasida mustahkamlandi.

Maze Therapeutics Corp (MAZE) - Narx-foyda koeffitsiyenti 14.08.2025dan 17.11.2026gacha

Maze Therapeutics, Inc. (MAZE) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning har tomonlama tahlili:Maze Therapeutics - MAZE
Maze Therapeutics yetakchi tovari

Compass genetik modellashtirish platformasining Maze Therapeutics Inc (MAZE) biznesiga integratsiyasi metabolik kasalliklar terapiyasi bo'yicha uning innovatsion ishlanmalarining qiymatini belgilaydi. Kompaniyaning choraklik P/E ko'rsatkichini tahlil qilish orqali investor bozor kapitalizatsiyasini sof foydaga nisbatan baholaydi, bu esa ushbu grafikka aktiv uchun to'lovning haddan tashqari ko'pligi darajasini aniqlash va joriy R&D xarajatlarini biznesning haqiqiy daromadliligiga bog'lash imkonini beradi.

Muhim raqobatchilar

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati WGS (GeneDx)|RARE: P/E multiplikatori|Beam Therapeutics Corp - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti SRPT|twistbioscience.com (TWST) - Biznesning o‘zini qoplash muddati|P/E multiplikatori TXG|NTLA (Intellia) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Stoke STOK|BioLife (BLFS) - Kapitalizatsiyaning foydaga nisbati|wavelifesciences.com - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati SION (Sionna Therapeutics Inc)|PRME: P/E multiplikatori|Taysha - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati uniQure NV|Narx-foyda multiplikatori MGTX (MeiraGTx PLC)|Narx-foyda koeffitsiyenti RGNX (regenxbio.com)|Solid Biosciences Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalizatsiyaning foydaga nisbati|BNTC - Narxning foydaga nisbati|Design Pharma - Bozor narxining sof foydaga nisbati|RCKT (Rocket Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|4D Molecular Therapeutics (FDMT) - P/E multiplikatori|Narxning foydaga nisbati Lexeo Therapeutics, Inc.|Kapitalizatsiyaning foydaga nisbati Korro Bio, Inc. KRRO|P/E multiplikatori EDIT|Biznesning o‘zini qoplash muddati Silence Therapeutics Corp|Narxning foydaga nisbati proqr.com PRQR|CDXS - Narx-foyda koeffitsiyenti|SGMO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Nautilus Biotechnology, Inc. (NAUT)|MGX: P/E multiplikatori|Narx-foyda multiplikatori DTIL|GBIO (Generation Bio) - P/E multiplikatori|Narx-foyda multiplikatori BOLD (boundlessbio.com)|Narx-foyda koeffitsiyenti XCUR (exicuretx.com)|Celsion Corporation - Narx-foyda multiplikatori|P/E multiplikatori PHIO (phiopharma.com)|P/E multiplikatori Mustang Bio, Inc. MBIO|RNAZ: Narx-foyda koeffitsiyenti|BNGO (Bionano Genomics) - Narx-foyda multiplikatori|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati